BIO Bio-Rad Laboratories Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: BIO
- Earnings
EPS in 2025 (TTM): -$24.21
Last Report Period Date: Sep 30, 2025
As of November this year, based on Bio-Rad Laboratories's most recent financial report, the company's trailing twelve months EPS is -$24.21. During 2024, BIO reported a per-share earnings of -$65.36, which shows a decrease compared to the EPS of -$21.82 recorded in 2023. Bio-Rad Laboratories's EPS for the quarterly period ending on Sep 30, 2025 came in at -$12.7.
BIO earnings history
The yearly earnings per share during 2024 was -$65.36, a decrease of 199.5% compared to -$21.82 recorded in 2023. Over the quarter ending Sep 30, 2025, the earnings per share came in at -$12.7, reflecting a 154.3% decline compared to the same quarter a year earlier. As of September 2025, the TTM EPS is -$24.21. During 2023, the annual earnings per share was -$21.82, representing an increase of 82.1% compared to 2022.
BIO EPS growth
Bio-Rad Laboratories has recorded a decline in earnings per share of 154.3% over the past 12 months (YoY, quarterly).
BIO Earnings Waterfall
BIO Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| JNJ Johnson & Johnson | 17.83 | -57.9% | -9.7% | 0.4% |
| BDX Becton Dickinson & Co | 32.07 | 18.3% | -5.3% | 8% |
| TMO Thermo Fisher Scientific Inc | 32.74 | 6.8% | -5.5% | 12.4% |
| A Agilent Technologies Inc | 34.29 | 5.2% | 3.7% | 5.4% |
| GE General Electric Co | 40.36 | -28.4% | N/A | N/A |
| DHR Danaher Corp | 43.49 | -17.2% | -15.3% | 5.3% |
| HBIO Harvard Bioscience Inc | N/A | -250% | N/A | N/A |
| BIO Bio-Rad Laboratories Inc | N/A | -199.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.